Muscle News and Research

RSS

Drug that targets phosphate does not improve CVD measures in patients with mild kidney disease

High phosphate levels in the blood carry increased heart-related risks, but taking a drug that targets phosphate does not improve cardiovascular measures in patients with mild kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

19 Apr 2013

UCSF Professor receives Olof Johnell Science Award for achievements in metabolic bone disease

Harry Genant, Professor Emeritus of the University of California San Francisco, has been named the winner of the International Osteoporosis Foundation's (IOF) first Olof Johnell Science Award.

19 Apr 2013

Study examines effect of slow walking speed in kidney disease patients

Kidney disease patients who have slower walking speed on physical performance tests seem to be more burdened by their disease than patients who perform well on lower extremity physical performance tests, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

19 Apr 2013

Knee brace can improve symptoms, function for people with knee osteoarthritis

Wearing a knee brace has been shown to "significantly improve the pain and symptoms" of a type of osteoarthritis affecting the kneecap, according to a new study.

From The University of Manchester 19 Apr 2013

New report reveals growing burden of osteoporosis in all 27 member states of EU

A new report prepared in collaboration with the International Osteoporosis Foundation and the European Federation of Pharmaceutical Industry Associations, is the first to describe in detail the epidemiology, burden, and treatment of osteoporosis in all 27 member states of the European Union.

18 Apr 2013

Study highlights importance of zebrafish as a model organism for human disease research

Researchers demonstrate today that 70 per cent of protein-coding human genes are related to genes found in the zebrafish and that 84 per cent of genes known to be associated with human disease have a zebrafish counterpart.

18 Apr 2013

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.

18 Apr 2013

Scientists reveal that stem cells, tissue-specific cells can be grown from mature mammalian cells

tem cells and tissue-specific cells can be grown in abundance from mature mammalian cells simply by blocking a certain membrane protein, according to scientists at the University of Pittsburgh School of Medicine and the National Institutes of Health.

18 Apr 2013

Scorecard compares how countries within EU care for people with osteoporosis

Today a panel of international experts working in cooperation with the International Osteoporosis Foundation have published SCOPE - or Scorecard for Osteoporosis in Europe.

18 Apr 2013

Examining function of all genes in zebrafish genome could benefit human health, researchers say

Equipped with the zebrafish genome, researchers have designed a method to assay the function of each and every gene and to explore the effects genetic variation has on zebrafish.

18 Apr 2013

Investigators report that cell-permeable NLS peptide shows promise in controlling atherosclerotic disease

Atherosclerosis - sometimes called "hardening of the arteries" - is a leading cause of death and morbidity in Western countries. A cell-permeable peptide containing the NF-ĸB nuclear localization sequence (NLS) shows promise as a potential agent in controlling the development of atherosclerotic disease.

18 Apr 2013

With Bio-patch sensor, health care can be moved into home, researcher says

The future of health care could be found in a tiny, paper-thin skin patch that collects vital information. The Bio-patch sensor developed by researchers at Stockholm's KTH Royal Institute of Technology is inexpensive, versatile and, best of all, comfortable to wear.

17 Apr 2013

COPD phase III study by Almirall and Forest Laboratories announces positive results

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall’s inhaler Genuair® (Pressair™ in the USA).

16 Apr 2013

Electroconvulsive therapy improves quality of life in patients with severe depression

Patients whose severe depression goes into remission for six months following electroconvulsive therapy report a quality of life similar to that of healthy individuals, researchers say.

16 Apr 2013

GTx to continue two pivotal Phase III clinical trials of enobosarm

GTx, Inc. today announced that a per protocol safety review of unblinded safety data on Friday April 12, 2013, by an independent Data Safety Monitoring Board, resulted in a determination that GTx continue as planned its two pivotal Phase III clinical trials of enobosarm (GTx-024) for the prevention and treatment of muscle wasting in patients with advanced non-small cell lung cancer.

16 Apr 2013

Athletes with vocal cord disorder inappropriately treated for exercise-induced asthma

Athletes with a vocal cord disorder that restricts breathing are more likely to be misdiagnosed and inappropriately treated for exercise-induced asthma, according to research presented today at the Triological Society's 116th Annual Meeting.

15 Apr 2013

Death of heart tissue could be prevented with new medicines, say TUSM scientists

A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's Center for Translational Medicine think could be prevented with new medicines.

15 Apr 2013

ACP unveils tools to improve health outcomes in patients following ACS event

The American College of Physicians today unveiled two evidence-based interventions and two videos to improve the health outcomes of patients in the first year following an initial acute coronary syndrome event such as heart attack and unstable angina (chest pain or discomfort but no part of the heart muscle dies), the most common indications of ACS.

15 Apr 2013

New group sets sights on curbing health care costs

The Partnership for Sustainable Health Care, which is made up of leaders representing insurers, employers, consumers and a hospital, aims to put political muscle behind ideas about controlling costs and boosting quality.

15 Apr 2013

NTU scientists develop new stroke rehabilitation device

Scientists from Nanyang Technological University have developed a new stroke rehabilitation device which greatly improves recovery in stroke patients.

12 Apr 2013

Muscle News and Research

Drug that targets phosphate does not improve CVD measures in patients with mild kidney disease

UCSF Professor receives Olof Johnell Science Award for achievements in metabolic bone disease

Study examines effect of slow walking speed in kidney disease patients

Knee brace can improve symptoms, function for people with knee osteoarthritis

New report reveals growing burden of osteoporosis in all 27 member states of EU

Study highlights importance of zebrafish as a model organism for human disease research

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

Scientists reveal that stem cells, tissue-specific cells can be grown from mature mammalian cells

Scorecard compares how countries within EU care for people with osteoporosis

Examining function of all genes in zebrafish genome could benefit human health, researchers say

Investigators report that cell-permeable NLS peptide shows promise in controlling atherosclerotic disease

With Bio-patch sensor, health care can be moved into home, researcher says

COPD phase III study by Almirall and Forest Laboratories announces positive results

Electroconvulsive therapy improves quality of life in patients with severe depression

GTx to continue two pivotal Phase III clinical trials of enobosarm

Athletes with vocal cord disorder inappropriately treated for exercise-induced asthma

Death of heart tissue could be prevented with new medicines, say TUSM scientists

ACP unveils tools to improve health outcomes in patients following ACS event

New group sets sights on curbing health care costs

NTU scientists develop new stroke rehabilitation device

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News